方法对我院15例耐万古霉素肠球菌感染的病例进行回顾性调查分析。
METHODS Investigation and analysis had been conducted for 15 cases of infection induced by VRE.
口服万古霉素用于治疗伪膜性肠炎促使了耐万古霉素肠球菌株的出现。
The use of oral vancomycin to treat pseudomembranous colitis contributed to the emergence of vancomycin-resistant enterococci51.
目的：对耐万古霉素的肠球菌进行表型及基因型分析，了解临床耐万古霉素肠球菌(VRE)的流行状况，指导临床合理使用抗生素。
Objectives: Through analyzing the phenotype and genotype of VRE, to investigate epidemiology of vancomycin-resistant enterococci strains (VRE) for instructing rational use of antibiotics in clinic.
以粪肠球菌为例：在传统养殖场，67%的细菌具有红霉素抗性；而在新型有机养殖场，抗药性细菌的比例只有18%。
Take Enterococcus faecalis: on the conventional farms 67 percent were resistant to the antibiotic erythromycin while only 18 percent were on the newly organic farms.
未发现耐万古霉素的葡萄球菌和肠球菌。
No vancomycin resistant Staphylococcus or Enterococcus was detected.
从土壤中分离得到一株放线菌ar 1148，其代谢产物对万古霉素耐药肠球菌有较明显的抑菌活性。
An actinomycetes strain AR1148 was isolated from soil and its metabolites could inhibit the growth of VRE (vancomycin resistant Enterococcus).
尚未发现耐万古霉素的葡萄球菌株及肠球菌株。
Staphylococcus and enterococcus resistant to vancomycin were not found.
结论万古霉素耐药肠球菌肺感染发病率呈上升趋势，病死率高，需引起临床的高度重视。
Conclusion the morbidity of nosocomial pulmonary infections caused by VRE is rising and the mortality is very high, and this problem is worthy of particular mention.
目的明确庆大霉素高水平耐药肠球菌（HLGR）新氨基糖苷类耐药基因及其传播机制。
Objective To identify the aminoglycoside resistance gene in the high-level gentamicin resistant (HLGR) enterococcus and its transmission mechanism.
未发现耐万古霉素的葡萄球菌和肠球菌。
No strain of Staphylococcus and Enterococcus resistant to vancomycin was found.
万古霉素耐药肠球菌（VRE）检出率为10.00%。
The detectable rate of Vancomycin-Resistant Enterococci (VRE) was 10.00%.
目的探讨万古霉素耐药肠球菌(VRE)的同源性及主要耐药机制。
ObjectiveTo investigate the homology and resistant mechanism of vancomycin-resistant Enterococci (VRE) isolates.
革兰阳性球菌中万古霉素抗菌活性最强，粪肠球菌对万古霉素耐药率为1.7%。
Vancomycin is the most potent antimicrobial agent against gram positive organisms with the resistant rate of Enterococcus faecalis at 1.7%.
目的了解高水平庆大霉素耐药(HLGR)的肠球菌的检出情况及肠球菌耐药性变迁。
Objective To study the high-level gentamicin resistance (HLGR) rate in Enterococcous SPP and the changes of antibiotic resistance of Enterococci.
耐万古霉素的肠球菌；耐药性；合理用药。
Vancomycin-resistant enterococci(VRE); Resistance; Rational drug use.
感染的肠球菌对万古霉素耐药的病人病死率最高，达92 % ，明显高于万古霉素敏感肠球菌肺感染的病死率（ 2 6% ） （P <0 0 5 ）。
The mortality of the patients infected by vancomycin-resistant enterococci was the highest (92%) and was higher than that of patients infected by vancomycin-sensitive enterococci (26%) ( P <0.05).
感染的肠球菌对万古霉素耐药的患者病死率最高。
Mortality case ofthe patients infected by vancomycin-resistant enterococci was the highest;
有5 0 .0 %的肠球菌感染不能用青霉素或粘肽类与氨基糖苷类联合用药。
The combined therapy with penicillins or vancomycin plus an aminoglycoside can not be used in 50.0% enterococci infection.
摘要：目的研究万古霉素耐药肠球菌(VRE)的耐药表型和基因特性。
Abstract: Objective To understand the susceptibility phenotype and genetic characteristics of vancomycin-resistant Enterococci (VRE).
肠球菌中部分菌株耐万古霉素。
肠球菌中部分菌株耐万古霉素。
应用推荐